Epidemiological trends of oropharyngeal and oral cavity squamous cell carcinomas in Northern New England, 2000–2013
- 48 Downloads
This study examines the epidemiological trends of oropharyngeal squamous cell carcinoma (OPSCC) and oral cavity squamous cell carcinoma (OCSCC) in Northern New England.
Data were obtained from the Maine, New Hampshire and Vermont cancer registries. The age-standardized incidence rates (ASIR), age-specific incidence rates, and annual percentage changes (APC) for OPSCC and OCSCC were calculated using Joinpoint regression.
The overall ASIR for OPSCC in Northern New England increased by 54.2% from 2000 to 2013 with an increase of 61.5% and 27.3% in men and women, respectively. Overall ASIR for OCSCC, on the other hand, declined throughout 2000 to 2013 by 6% and among men by 11%. In joinpoint analyses, the overall ASIRs for OPSCC significantly increased at an APC of 3.15 from 2000 to 2013, whereas the ASIRs for OCSCC remained stable at an APC of − 0.26. In men, ASIRs for OPSCC significantly increased (APC: 3.46), while that of OCSCC remained stable at an APC of − 0.87. In women, the ASIRs remained stable for both OPSCC and OCSCC at an APC of 1.97 and 0.49, respectively. For patients in the 6th decade of life, the age-specific incidence rates for OPSCC increased significantly at an APC of 3.06, also among those in the 7th and 8th decade with a significant increase at an APC of 4.98 and 3.51 per year, respectively. There were no significant changes in the APC of patients with OCSCC with respect to age group.
The overall incidence of OPSCC is increasing in Northern New England, specifically among men. Given the etiological association between OPSCC and HPV, vaccination against HPV should be effectively encouraged among the populace. The efforts on tobacco cessation, abstinence, and alcohol abuse control should be continually expanded in order to bring about a decreasing trend in OCSCC.
KeywordsHPV Oropharynx Head and neck cancer Maine New Hampshire Vermont
This project was supported in part by the Centers for Disease Control and Prevention’s National Program of Cancer Registries, cooperative agreement 5U58DP003930 awarded to the New Hampshire Department of Health and Human Services, Division of Public Health Services, Bureau of Public Health Statistics and Informatics, Office of Health Statistics and Data Management. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the New Hampshire Department of Health and Human Services. This project was also supported in part by the cooperative agreement 1NU58DP006297 funded by the Centers for Disease Control and Prevention awarded to the Maine Department of Health and Human Services. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Maine Centers for Disease Control and Prevention or the Department of Health and Human Services. We would like to thank Maine, New Hampshire and Vermont Cancer Registries for sharing the states data.
Compliance with ethical standards
Conflict of interest
All authors declare that there are no financial conflicts associated with this study.
- 1.Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Group WHOIAfRoCMW (2009) A review of human carcinogens—part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10(11):1033–1034CrossRefGoogle Scholar
- 7.Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER, Workgroup HPVToC (2014) Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis 20(5):822–828. https://doi.org/10.3201/eid2005.131311 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease C, Prevention, Advisory Committee on Immunization P (2007) Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56(RR-2):1–24PubMedGoogle Scholar
- 13.Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparen P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125(2):362–366. https://doi.org/10.1002/ijc.24339 CrossRefPubMedGoogle Scholar
- 14.Bhosale PG, Pandey M, Desai RS, Patil A, Kane S, Prabhash K, Mahimkar MB (2016) Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol 122(5):609–618. https://doi.org/10.1016/j.oooo.2016.06.006 CrossRefPubMedGoogle Scholar
- 20.Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301. https://doi.org/10.1200/JCO.2011.36.4596 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Boscolo-Rizzo P, Zorzi M, Del Mistro A, Da Mosto MC, Tirelli G, Buzzoni C, Rugge M, Polesel J, Guzzinati S, Group AW (2018) The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas? PLoS ONE 13(2):e0192621. https://doi.org/10.1371/journal.pone.0192621 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Jehannin-Ligier K, Belot A, Guizard AV, Bossard N, Launoy G, Uhry Z, Network F (2017) Incidence trends for potentially human papillomavirus-related and -unrelated head and neck cancers in France using population-based cancer registries data: 1980–2012. Int J Cancer 140(9):2032–2039. https://doi.org/10.1002/ijc.30631 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.van Monsjou HS, Schaapveld M, van den Brekel MW, Balm AJ (2015) The epidemiology of head and neck squamous cell carcinoma in the Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change? Oral Oncol 51(10):901–907. https://doi.org/10.1016/j.oraloncology.2015.06.011 CrossRefPubMedGoogle Scholar
- 27.Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep 66(33):874–882. https://doi.org/10.15585/mmwr.mm6633a2 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Han JJ, Beltran TH, Song JW, Klaric J, Choi YS (2017) Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013–2014. JAMA Oncol 3(6):810–816. https://doi.org/10.1001/jamaoncol.2016.6192 CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Vazquez-Otero C, Vamos CA, Thompson EL, Merrell LK, Griner SB, Kline NS, Catalanotto FA, Giuliano AR, Daley EM (2018) Assessing dentists’ human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc 149(1):9–17. https://doi.org/10.1016/j.adaj.2017.08.021 CrossRefPubMedGoogle Scholar
- 36.American Dental Association Statement on human papilomavirus and cancers of the oral cavity and oropharynx. https://www.ada.org/en/about-the-ada/ada-positions-policies-and-statements/statement-on-human-papillomavirus-and-squamous-cel. Accessed 18 May 2018
- 37.U.S. Department of Health and Human Services (2014) The health consequences of smoking-50 years of progress: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, AtlantaGoogle Scholar
- 38.U.S. Department of Health and Human Services (2016) E-cigarette use among youth and young adults: a report of the surgeon general-executive summary. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, AtlantaGoogle Scholar
- 39.Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, Stone MD, Khoddam R, Samet JM, Audrain-McGovern J (2015) Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 314(7):700–707. https://doi.org/10.1001/jama.2015.8950 CrossRefPubMedPubMedCentralGoogle Scholar
- 40.Haughwout SP, LaVallee RA, Castle IP (2016) Apparent per Capita Alcohol Consumption: National, State, and Regional Trends, 1977–2014 (SURVEILLANCE REPORT #104). National Institute on Alcohol Abuse and Alcoholism Division of Epidemiology and Prevention Research Alcohol Epidemiologic Data SystemGoogle Scholar